LSIMF Round 7
Supports United Kingdom life science manufacturing teams through LSIMF grants for facility and process innovation.
The Life Sciences Innovative Manufacturing Fund (LSIMF) is a DSIT programme operated by the Office for Life Sciences, a joint DSIT/DHSC body, offering up to £520 million in capital grants through to 31 March 2030 to strengthen UK manufacturing capacity for life sciences products. Round 7, the current quarterly window, opened 1 May 2026 and closed 29 May 2026 at noon; Round 8 opens 3 August 2026 an…
Funds capital investment in UK manufacturing capacity for human medicines (APIs and finished products), medical diagnostics, and MedTech devices meeting MHRA regulatory standards.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline